Jefferies Downgrades Halozyme Therapeutics (HALO) to Hold

Go back to Jefferies Downgrades Halozyme Therapeutics (HALO) to Hold
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 105.01 +2.01 (1.95%)
Previous Close $103.00    52 Week High $18.39 
Open $102.95    52 Week Low $6.96 
Day High $105.11    P/E N/A 
Day Low $102.39    EPS $-0.58 
Volume 930,935